Literature DB >> 24558025

Prognostic role of tumor size in T1 HER2-positive breast cancers treated with adjuvant trastuzumab.

M Campiglio1, M Sandri, M Sasso, F Bianchi, A Balsari, S Ménard, E Tagliabue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24558025     DOI： 10.1093/annonc/mdu058

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Neoadjuvant chemotherapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and docetaxel.

Authors:  Xi Gu; Shi Jia; Wei Wei; Wen-Hai Zhang
Journal:  Tumour Biol       Date:  2015-02-15

2.  Prognostic value of tumor size in patients with remnant gastric cancer: is the seventh UICC stage sufficient for predicting prognosis?

Authors:  Jun Lu; Chang-ming Huang; Chao-hui Zheng; Ping Li; Jian-wei Xie; Jia-bin Wang; Jian-xian Lin; Qi-yue Chen; Long-long Cao; Mi Lin
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.